<DOC>
	<DOCNO>NCT01001988</DOCNO>
	<brief_summary>This follow-up Study JEC02 ( NCT 00735644 ) design characterize persistence neutralize antibody five year vaccination Japanese encephalitis chimeric vaccine ( JE-CV ) . Primary Objective : - To describe yearly persistence humoral immune response Japanese encephalitis single dose JE-CV</brief_summary>
	<brief_title>Long-term Follow-up Immunogenicity Single Dose Japanese Encephalitis Chimeric Virus Vaccine Toddlers</brief_title>
	<detailed_description>Immunogenicity persistence determine subset participant previously receive single dose Japanese encephalitis chimeric virus vaccine age 12 18 month Study JEC02 ( NCT 00735644 ) . No vaccination give study .</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Provision Informed Consent Form sign least one parent legally acceptable representative , least one independent witness require local regulation . Subject vaccinated Japanese encephalitis chimeric vaccine ( JECV ) JEC02 trial prevaccination blood sample baseline JEC02 trial . Subject parent/legally acceptable representative able attend schedule visit comply trial procedure . Exclusion Criteria : Receipt JE vaccine JECV JEC02 trial period inclusion JEC05 trial . Planned participation another clinical trial present trial period .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Encephalitis</keyword>
	<keyword>Japanese Encephalitis</keyword>
	<keyword>Japanese Encephalitis Chimeric Virus Vaccine</keyword>
	<keyword>Toddlers</keyword>
</DOC>